GENETIC TESTING

Lack of Utility Evidence Still Hampers Adoption of Pharmacogenomic Testing: Benefits Seen in the Field of Psychiatry

For years it had been hoped that pharmacogenetic (PGx) testing would be a leading application for personalized medicine, but adoption of PGx testing has not lived up to its potential and remains in an … [Read more...]

PRECISION MEDICINE

New Study Provides Most Comprehensive Overview of Genetic Test Development, Usage and Spending

As might be expected, there has been rapid growth in genetic test availability and spending on these tests since 2014. But, comprehensive new collaborative analysis conducted by Concert Genetics … [Read more...]

GENETIC TESTING

Inside the Diagnostics Industry: Genotyping to Guide Antiplatelet Selection Feasible, Effective

Despite years of frustration that pharmacogenomic testing for antiplatelet therapy dosing has not been adopted as hoped in the field of cardiology, new evidence is emerging that genetic testing should … [Read more...]

SAFETY

Diagnostic danger in the lab: Time to reform how we process orders

By Oleg Bess, M.D.  bio I don't know about you, but I was stunned by the findings from a recent report published by Coverys, a national liability insurer, which I feel should put the entire … [Read more...]

GENETIC TESTING

Tests Emerging to Advance Cardiovascular Risk Assessment

While testing for cardiovascular conditions does not garner the headlines that oncology testing does, several recent studies demonstrate how the introduction of genetic testing and other new testing … [Read more...]

ANNUAL SURVEY

Outreach Survey Focuses on Clinical Laboratory Industry Trends Amidst Greatest Disruption in Three Decades

By Jeff Myers  bio Accumen Inc. is pleased to announce the launch of the 17th Annual National Hospital and Health System Laboratory and Outreach Survey. The survey is designed to capture … [Read more...]

INDUSTRY TRENDS

FDA’s Two Big Moves on NGS-Based Tumor Panels May Offer Clues for Alternative Pathways for LDT Approval

In late November the U.S. Food and Drug Administration (FDA) authorized Memorial Sloan Kettering Cancer Center's Integrated Mutation Profiling of Actionable Cancer Targets tumor profiling test assay … [Read more...]

INDUSTRY TRENDS

Inside the Diagnostics Industry: Laboratory Data Core to Value-Based Health Care

To thrive in the present challenging environment, laboratories need to deliberately focus on how they can create value outside of their own walls. The key to achieving this is in their data. Speakers … [Read more...]

INDUSTRY TRENDS

Diagnostics Industry Responding to Opioid Epidemic

Prescription opioids are among the most common drugs prescribed and are the most effective treating for pain, whether it is debilitating, chronic pain or temporary pain, such as after surgery. While … [Read more...]

INDUSTRY TRENDS

Curetis to Launch Multiplex MDx for Hospital Infections in U.S.

Molecular diagnostics firm Curetis (Germany) specializes in solutions to rapidly diagnose and profile antibiotic resistance for severe infections in hospitalized patients. The company currently has … [Read more...]


(-0000g2)